Prader–Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review
International Journal of Molecular Sciences · 21.02.2023 · 24 (5) · 4271
DOI: 10.3390/ijms24054271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.02.2023. Verfasst von Merlin G Butler. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Blvd., MS 4015, Kansas City, MO 66160, USA. Hauptthemen laut MEDLINE: Prader-Willi Syndrome. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Child Health and Human Development (NICHD) and U54.
Abstract (Originalsprache)
Prader–Willi syndrome (PWS) is a complex genetic disorder with three PWS molecular genetic classes and presents as severe hypotonia, failure to thrive, hypogonadism/hypogenitalism and developmental delay during infancy. Hyperphagia, obesity, learning and behavioral problems, short stature with growth and other hormone deficiencies are identified during childhood. Those with the larger 15q11-q13 Type I deletion with the absence of four non-imprinted genes (NIPA1, NIPA2, CYFIP1, TUBGCP5) from the 15q11.2 BP1-BP2 region are more severely affected compared with those with PWS having a smaller Type II deletion. NIPA1 and NIPA2 genes encode magnesium and cation transporters, supporting brain and muscle development and function, glucose and insulin metabolism and neurobehavioral outcomes. Lower magnesium levels are reported in those with Type I deletions. The CYFIP1 gene encodes a protein associated with fragile X syndrome. The TUBGCP5 gene is associated with attention-deficit hyperactivity disorder (ADHD) and compulsions, more commonly seen in PWS with the Type I deletion. When the 15q11.2 BP1-BP2 region alone is deleted, neurodevelopment, motor, learning and behavioral problems including seizures, ADHD, obsessive-compulsive disorder (OCD) and autism may occur with other clinical findings recognized as Burnside–Butler syndrome. The genes in the 15q11.2 BP1-BP2 region may contribute to more clinical involvement and comorbidities in those with PWS and Type I deletions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Blvd., MS 4015, Kansas City, MO 66160, USA.
ORCID-Profile: Merlin G Butler
Förderung
- National Institute of Child Health and Human Development (NICHD) and U54
Zitieren
APA
Butler, M. G. (2023). Prader–Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review. International Journal of Molecular Sciences, 24(5), 4271. https://doi.org/10.3390/ijms24054271
Vancouver
Butler MG. Prader–Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review. International Journal of Molecular Sciences. 2023;24(5):4271. doi:10.3390/ijms24054271
BibTeX
@article{Butler2023,
author = {Butler, Merlin G},
title = {Prader–Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {5},
pages = {4271},
doi = {10.3390/ijms24054271}
}
EUVIMED